# A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters

> **NCT00396032** · PHASE3 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 150 (actual)

## Conditions studied

- Dysfunctional Hemodialysis Catheters

## Interventions

- **DRUG:** placebo
- **DRUG:** tenecteplase

## Key facts

- **NCT ID:** NCT00396032
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-12
- **Final completion:** —
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2010-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396032, "A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00396032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*